CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
MorphoSys AG Company Snapshot
MorphoSys AG operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares MorphoSys AG with three other miscellaneous service companies in Europe: Innate Pharma S.A. of France (2016 sales of 56.16 million Euro [US$64.48 million] of which 100% was Licensing Revenue), Cellectis SA of France (51.01 million Euro [US$58.56 million] of which 105% was Therapeutics), and Ergomed PLC which is based in the United Kingdom (£39.23 million [US$51.22 million] of which 67% was Clinical Research Service).

Sales Analysis. During the year ended December of 2016, sales at MorphoSys AG were 49.74 million Euro (US$57.11 million). This is a sharp decrease of 53.2% versus 2015, when the company's sales were 106.22 million Euro. Contributing to the drop in overall sales was the 99.0% decline in Proprietary Development, from 59.94 million Euro to 621,000.00 Euro. . However, these declines were partially offset by the increase in sales of Partnered Discovery (up 6.1% to 49.12 million Euro) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
MorphoSys AG
  Stock Performance Chart for MorphoSys AG
 
  Stock Data: Recent Stock Performance:
  Current Price (7/14/2017): 66.80
(Figures in Euro)
1 Week 9.8%   13 Weeks 5.4%  
4 Weeks 26.7%   52 Weeks 70.5%  
 
MorphoSys AG Key Data:
  Ticker: MOR Country: Germany
  Exchanges: DUS FRA OTH Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 49,743,515
(Year Ending Jan 2017).
Employees: 345
  Currency: Euro Market Cap: 1,922,054,102
  Fiscal Yr Ends: December Shares Outstanding: 28,773,265
  Share Type: Stammaktie Closely Held Shares: 2,012,132
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.